A Phase 2 Randomized Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of a Single Intrathecal Preoperative Administration of AYX1 Injection in Patients Undergoing Unilateral Total Knee Arthroplasty
Phase of Trial: Phase II
Latest Information Update: 27 Apr 2017
At a glance
- Drugs AYX 1 (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Adynxx
- 22 Apr 2017 Planned End Date changed from 1 Aug 2017 to 1 Jan 2018.
- 22 Apr 2017 Planned primary completion date changed from 1 Aug 2017 to 1 Nov 2017.
- 01 Mar 2017 According to a Adynxx media release, the first patient was dosed in this study.